Skip to main content

Advertisement

Log in

Combined PET/CT with iodine-124 in diagnosis of spread metastatic thyroid carcinoma: a case report

  • Nuclear Medicine
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Iodine-124 positron emission tomography (PET) is a useful 3D imaging technique for diagnosis and management of thyroid diseases. The difficulty in interpretation of the PET scans with highly selective tracers, such as iodine-124, is the lack of identifiable anatomical structures, so an accurate anatomical localization of foci presenting abnormal uptake is problematic. Consequently, a combined PET/CT scanner can resolve these difficulties by co-registering PET and CT data in a single session allowing a correlation of functional and morphologic imaging. A case is presented where iodine-124 produced by a clinical cyclotron and FDG were used to acquire images with a combined PET/CT scanner for clinical staging. On the basis of the PET/CT exams the treatment of the patient was modified.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.

Similar content being viewed by others

References

  1. Frilling A, Tecklenborg K, Görges R, Weber F, Clausen M, Broelsch EC (2001) Preoperative diagnostic value of fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma. Ann Surg 234:804–811

    Article  CAS  PubMed  Google Scholar 

  2. Frilling A, Görges R, Tecklenborg K, Gassmann P, Bockhorn M, Clausen M, Broelsch CE (2000) Value of preoperative diagnostic modalities in patients with recurrent thyroid carcinoma. Surgery 128:1067–1074

    Article  CAS  PubMed  Google Scholar 

  3. Alnafisi NS, Driedger AA, Coates G, Moote DJ, Raphael SJ (2000) FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma. J Nucl Med 41:1010–1015

    CAS  PubMed  Google Scholar 

  4. Bakheet SM, Powe JE, Hammami MM, Ahmed M (1997) Comparison of F-18 FDG to I-123 and I-131 scans in thyroid carcinoma. Clin Nucl Med 22:438–439

    Article  CAS  PubMed  Google Scholar 

  5. Chung JK, So Y, Lee JS, Choi CW, Lim SM, Lee DS, Hong SW, Youn YK, Lee MC, Cho BY (1999) Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan. J Nucl Med 40:986–992

    Google Scholar 

  6. Grunwald F, Kalicke T, Feine U, Lietzenmayer R, Scheidhauer K, Dietlein M, Schober O, Lerch H, Brandt-Mainz K, Burchert W, Hiltermann G, Cremerius U, Biersack HJ (1999) Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre study. Eur J Nucl Med 26:1547–1552

    Article  CAS  PubMed  Google Scholar 

  7. Helal BO, Merlet P, Toubert ME, Franc B, Schvartz C, Gauthier-Koelesnikov H, Prigent A, Syrota A (2001) Clinical impact of FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative scanning results after therapy. J Nucl Med 42:1464–1469

    CAS  PubMed  Google Scholar 

  8. Hooft L, Hoekstra OS, Deville W, Lips P, Teule GJ, Boers M, van Tulder MW (2001) Diagnostic accuracy of 18F-fluorodeoxyglucose positron emission tomography in the follow-up of papillary or follicular thyroid cancer. J Clin Endocrinol Metab 86:3779–3786

    CAS  PubMed  Google Scholar 

  9. Mechanick JI, Kim CK, Krynyckyi BR, Machac J, Urken ML (2000) Multiple papillary thyroid carcinoma metastases revealed on position emission tomography scan in a patient with negative 131I scan. Thyroid 10:929–930

    CAS  PubMed  Google Scholar 

  10. van Tol KM, Jager PL, Dullaart RP, Links TP (2000) Follow-up in patients with differentiated thyroid carcinoma with positive 18F-fluoro-2-deoxy-D-glucose-positron emission tomography results, elevated thyroglobulin levels, and negative high-dose 131I posttreatment whole body scans. J Clin Endocrinol Metab 85:2082–2083

    Google Scholar 

  11. Wang W, Larson SM, Fazzari M, Tickoo SK, Kolbert K, Sgouros G, Yeung H, Macapinlac H, Rosai J, Robbins RJ (2000) Prognostic value of fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer. J Clin Endocrinol Metab 85:1107–1113

    CAS  PubMed  Google Scholar 

  12. Lambrecht RM, Woodhouse N, Phillips R, Wolczak D, Qureshi A, Reyes ED, Graser C, Al-Yanbawi S, Al-Rabiah A, Meyer W et al. (1988) Investigational study of iodine-124 with a positron camera. Am J Physiol Imaging 3:197–200

    CAS  PubMed  Google Scholar 

  13. Crawford DC, Flower MA, Pratt BE, Hill C, Zweit J, McCready VR, Harmer CL (1997) Thyroid volume measurement in thyrotoxic patients: comparison between ultrasonography and iodine-124 positron emission tomography. Eur J Nucl Med 24:1470–1478

    CAS  PubMed  Google Scholar 

  14. Erdi YE, Macapinlac H, Larson SM, Erdi AK, Yeung H, Furhang EE, Humm JL (1999) Radiation dose assessment for I-131 therapy of thyroid cancer using I-124 PET imaging. Clin Pos Imaging 2:41–46

    Article  Google Scholar 

  15. Flower MA, al-Saadi A, Harmer CL, McCready VR, Ott RJ (1994) Dose-response study on thyrotoxic patients undergoing positron emission tomography. Eur J Nucl Med 21:531–536

    CAS  PubMed  Google Scholar 

  16. Frey P, Townsend D, Flattet A, De Gautard R, Widgren S, Jeavons A, Christin A, Smith A, Long A, Donath A (1986) Tomographic imaging of the human thyroid using 124I. J Clin Endocrinol Metab 63:918–927

    CAS  PubMed  Google Scholar 

  17. Frey P, Townsend D, Jeavons A, Donath A (1985) In vivo-imaging of the human thyroid with a positron camera using 124I. Eur J Nucl Med 10:472–476

    CAS  PubMed  Google Scholar 

  18. Pentlow KS, Graham MC, Lambrecht RM, Daghighian F, Bacharach SL, Bendriem B, Finn RD, Jordan K, Kalaigian H, Karp JS, Robeson WR, Larson SM (1996) Quantitative imaging of iodine-124 with PET. J Nucl Med 37:1557–1562

    CAS  PubMed  Google Scholar 

  19. Eschmann SM, Reischl G, Bilger K, Kupferschlager J, Thelen MH, Dohmen BM, Besenfelder H, Bares R (2002) Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET. Eur J Nucl Med 29:760–767

    Article  CAS  Google Scholar 

  20. Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R, Jerin J, Young J, Byars L, Nutt R (2000) A combined PET/CT scanner for clinical oncology. J Nucl Med 41:1369–1379

    CAS  PubMed  Google Scholar 

  21. Townsend DW, Cherry SR (2001) Combined anatomy and function: the path of true image fusion. Eur Radiol 11:1968–1974

    CAS  PubMed  Google Scholar 

  22. Maxon HR (1999) Quantitative radioiodine therapy in the treatment of differentiated thyroid cancer. Q J Nucl Med 43:313–323

    Google Scholar 

  23. Maxon HR, Thomas SR, Samaratunga RC (1997) Dosimetric considerations in the radioiodine treatment of macrometastases and micrometastases from differentiated thyroid cancer. Thyroid 7:183–187

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to L. S. Freudenberg.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Freudenberg, L.S., Antoch, G., Görges, R. et al. Combined PET/CT with iodine-124 in diagnosis of spread metastatic thyroid carcinoma: a case report. Eur Radiol 13 (Suppl 6), L19–L23 (2003). https://doi.org/10.1007/s00330-003-1884-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-003-1884-x

Keywords

Navigation